The question of drug combinations for consolidation and maintenance for multiple myeloma
Why daratumumab will become key for the treatment of multiple myeloma
Immunotherapy for multiple myeloma: current research avenues
Re-treatment of patients refractory to daratumumab
Heinz Ludwig et al.
Myeloma 2016: Panel discussion on gene modified T-cells
Edward Stadtmauer et al.